CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE | Government contract · CanPursue
Contracts
active

ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE

CHU Ste-JustineNovartis Pharma Canada inc.7839
Watch
Total contract value
$22.5M
Original award value
$22.5M
Start
Sep 10, 2024
End
—

Timeline

Official
  • AwardedSep 10, 2024. Original award value: $22.5M
Contract number
7839
Awarded
Sep 10, 2024
Instrument
—
Status
active
Amendments
0 amendments
Source
SEAO
20009260
Related procurement
View full record